Alterations in FGFRs such as mutations, amplifications, and fusions can result in uncontrolled cell proliferation, survival, and angiogenesis, contributing to cancer development and progression. For instance, FGFR1 amplification has been observed in breast cancer, while FGFR2 mutations are common in endometrial cancer.